|
Michael D. Young M.D. Ph.D. has served as a director since September 2002. Dr. Young has more than 25 years of experience in the pharmaceutical industry with significant management experience in the areas of clinical research and development pre-clinical development and worldwide regulatory affairs. Prior to joining our board of directors he served as development director chief scientific officer for London-based Celltech PLC a leading European biotechnology company where he was responsible for all research and strategic product development. During his tenure Celltech developed five new products. Previously Dr. Young was corporate director worldwide regulatory and clinical development for The Procter & Gamble Company. He has also held senior positions at SmithKline Beckman Corp. French Laboratories Astra Pharmaceuticals and Delbay Pharmaceuticals (a joint-venture between Bayer and Schering Plough). | 